#PeriodontalDisease causes #BoneLoss & #Inflammation.
Study shows GSK J4 attenuates these effects by targeting #JMJD3 — highlighting #epigenetic modulation as a promising therapeutic strategy. #medsky
Read: doi.org/10.1007/s115...
@currentmedscience.bsky.social